Sartorius Stedim Biotech S.A.
SDMHF
$193.02
-$26.41-12.04%
OTC PK
| 12/31/2025 | 06/30/2025 | 12/31/2024 | 09/30/2024 | ||
|---|---|---|---|---|---|
| Net Income | -- | -- | 189.43M | 184.31M | |
| Total Depreciation and Amortization | -- | -- | 280.88M | 280.97M | |
| Total Amortization of Deferred Charges | -- | -- | 44.98M | 25.41M | |
| Total Other Non-Cash Items | -- | -- | 94.89M | 149.69M | |
| Change in Net Operating Assets | -- | -- | 270.65M | 298.50M | |
| Cash from Operations | -- | -- | 880.84M | 938.87M | |
| Capital Expenditure | -- | -- | -367.54M | -392.94M | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | 0.00 | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | -- | -213.20K | -2.58M | |
| Cash from Investing | -- | -- | -367.75M | -395.52M | |
| Total Debt Issued | -- | -- | 17.30M | 13.60M | |
| Total Debt Repaid | -- | -- | -879.20M | -982.60M | |
| Issuance of Common Stock | -- | -- | 1.20B | 1.20B | |
| Repurchase of Common Stock | -- | -- | -5.90M | -5.90M | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -72.22M | -72.22M | |
| Other Financing Activities | -- | -- | -177.80M | -272.20M | |
| Cash from Financing | -- | -- | 93.67M | -124.46M | |
| Foreign Exchange rate Adjustments | -- | -- | 2.45M | -426.80K | |
| Miscellaneous Cash Flow Adjustments | -- | -- | 108.60K | 108.60K | |
| Net Change in Cash | -- | -- | 609.30M | 418.57M | |